Literature DB >> 20350235

Haemoglobin Stanleyville II modifies sickle disease phenotype.

Genia Burchall, Ellen Maxwell.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20350235     DOI: 10.3109/00313021003631197

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  4 in total

1.  Hb S/β+-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the β locus control region.

Authors:  Ali Amid; Melina Cheong; Barry Eng; Meredith Hanna; Betty-Ann Hohenadel; Lisa M Nakamura; Lynda Walker; Isaac Odame; Melanie Kirby-Allen; John S Waye
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

2.  Hemoglobin variants identified in the Uganda Sickle Surveillance Study.

Authors:  Beverly A Schaefer; Charles Kiyaga; Thad A Howard; Grace Ndeezi; Arielle G Hernandez; Isaac Ssewanyana; Mary C Paniagua; Christopher M Ndugwa; Jane R Aceng; Russell E Ware
Journal:  Blood Adv       Date:  2016-11-22

3.  Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation.

Authors:  Martin K Safo; Tzu-Ping Ko; Eric R Schreiter; J Eric Russell
Journal:  J Mol Struct       Date:  2015-11-05       Impact factor: 3.196

Review 4.  Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.

Authors:  Piyusha P Pagare; Aref Rastegar; Osheiza Abdulmalik; Abdelsattar M Omar; Yan Zhang; Andrew Fleischman; Martin K Safo
Journal:  Expert Opin Ther Pat       Date:  2021-11-01       Impact factor: 6.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.